Rocket Pharmaceuticals, Inc. Accounts Payable
Rocket Pharmaceuticals, Inc. (RCKT) had Accounts Payable of $66.00 thousand as of 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2018-08-14
- 2018-06-30: Accounts Payable, Current $66.00K.
- 2018-03-31: Accounts Payable, Current $67.00K.
- 2017-12-31: Accounts Payable, Current $0.00; Accounts Payable, Current as first filed $451.00K.
- 2017-09-30: Accounts Payable, Current $383.00K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2018-06-30 | $66.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $67.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-14 | $451.00K 10-K · filed 2018-03-07 |
| 2017-09-30 | $383.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $368.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.90M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.59M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $1.78M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $921.00K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $1.38M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $1.63M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $1.71M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $813.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.30M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $1.15M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |